Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-912-4 | CAS number: 2935-90-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- N/A to 1983-08-19
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study was conducted similar to OECD guideline 402 (Acute Dermal Toxicity) with limited details on test material and methods.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- limited details on test material and methods
- Principles of method if other than guideline:
- N/A
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Methyl 3-mercaptopropionate
- EC Number:
- 220-912-4
- EC Name:
- Methyl 3-mercaptopropionate
- Cas Number:
- 2935-90-2
- Molecular formula:
- C4H8O2S
- IUPAC Name:
- methyl 3-sulfanylpropanoate
- Details on test material:
- - Name of test material (as cited in study report): methyl 3-mercaptopropionate
- Molecular formula (if other than submission substance): N/A
- Molecular weight (if other than submission substance): N/A
- Smiles notation (if other than submission substance): N/A
- InChl (if other than submission substance): N/A
- Structural formula attached as image file (if other than submission substance): N/A
- Substance type: active
- Physical state: liquid
- Stability under test conditions: N/A
- Storage condition of test material: N/A
- Other: N/A
Constituent 1
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Dutchland Laboratory Animals, Inc.
- Age at study initiation: young adult
- Weight at study initiation: 2 to 3 kg
- Fasting period before study: N/A
- Housing: individual
- Diet: Purina lab Rabbit Chow, ad libitum
- Water: tap water, ad libitum
- Acclimation period: minimum of one week
ENVIRONMENTAL CONDITIONS
- Temperature (deg. C): 70 +/- 4 degrees F
- Humidity (%): 40-60%
- Air changes (per hr): N/A
- Photoperiod (hrs dark / hrs light): 12 hour light-dark cycle
IN-LIFE DATES: From: N/A To: N/A
Administration / exposure
- Type of coverage:
- other: do not have enough information but know it is not open.
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: Area was shaved off 24 hours prior to initiation of the study and liquid test material was applied to the back
- % coverage: approximately 10% of the total body surface
- Type of wrap if used: non-absorbent binder
REMOVAL OF TEST SUBSTANCE
- Washing (if done): The exposed area of the animals was wiped (but not waashed) to remove any test material remaining.
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): N/A
- Concentration (if solution): N/A
- Constant volume or concentration used: N/A
- For solids, paste formed: N/A
VEHICLE
- Amount(s) applied (volume or weight with unit): N/A
- Concentration (if solution): N/A
- Lot/batch no. (if required): N/A
- Purity: N/A - Duration of exposure:
- 24 hours
- Doses:
- 1000, 1500, 2000, and 2500 mg/kg bw
- No. of animals per sex per dose:
- 3/sex/dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days.
- Frequency of observations and weighing: Body weights were recorded at study initiation, at Day 7 and Day 14.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,dermal irritation, gross pathology. Skin was evaluated on Days 1, 3, 7, 10, and 14. - Statistics:
- N/A
Results and discussion
- Preliminary study:
- N/A
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 930.4 mg/kg bw
- 95% CL:
- 1 222.5 - 3 048.5
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 890.8 mg/kg bw
- 95% CL:
- 1 383.6 - 2 583.8
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 903.7 mg/kg bw
- 95% CL:
- 1 462.1 - 2 478.7
- Mortality:
- All animals in the 1000 mg/kg dose group survived. In the 1500 mg/kg dose group, one male died after one hour, one male and one female died after 4 hours. In the 2000 mg/kg dose group, one male and one female died after 1 hour, one female died after 4 hours. Two males in the 2500 mg/kg dose group died after 4 hour, two females in the 2500 dose group died after 1 hour.
- Clinical signs:
- other: All animals dosed at 1000 mg/kg bw appeared normal during the study with exception of slight depression in one male at 1 hour and one female at 4 hours. Effects of toxicity in the remaining animals were noted by 1 hour post dosing and included one or mor
- Gross pathology:
- Gross pathological findings among rabbits found dead were limited to dark red lungs in one female dosed at 2000 mg/kg bw. There were no observable gross pathological findings related to test material administration in any of the rabbits surviving to termination.
- Other findings:
- - Other observations: Irritation: With one exception, dermal irritation scores could not be made in the animals that died during the study because they were found dead prior to Day 1 observation. No dermal irritation was noted on Day 1 in the one female dosed at 2000 mg/kg bw that was found dead on Day 2. Erythema among survivors ranged from very slight to well-defined. Very slight erythema was noted in one female dosed at 1000 mg/kg on Day 3 and in one male and two females dosed at 1500 mg/kg on Day 1 only. Well-defined erythema was noted in one male and one female dosed at 2500 mg/kg bw on Day 1 and decreased in the male to very slight on Day 3, clearing in the female by Day 3 and in the male by Day 7. No edema was noted in any of the animals. Other dermal effects were noted in anlmals dosed at 2000 mg/kg. Epidermal scaling was noted in one male on Days 7 and 14 and one female on Day 14. Necrosis was noted in one male and female on Day 10 only.
Any other information on results incl. tables
Individual Dermal Irritation Scores Using Draize Scale for Scoring Dermal Irritation |
||||||||||
Animal No. |
Erythema Score |
Edema Score |
||||||||
|
Day |
Day |
||||||||
|
1 |
3 |
7 |
10 |
14 |
1 |
3 |
7 |
10 |
14 |
1000 mg/kg bw |
|
|
||||||||
Male 1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Male 2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Male 3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Female 1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Female 2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Female 3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1500 mg/kg bw |
|
|
||||||||
Male 1 |
Found dead |
Found dead |
||||||||
Male 2 |
Found dead |
Found dead |
||||||||
Male 3 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Female 1 |
1 |
0 |
0 |
0 |
|
0 |
0 |
0 |
0 |
0 |
Female 2 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Female 3 |
Found dead |
Found dead |
||||||||
2000 mg/kg bw |
|
|
||||||||
Male 1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Male 2 |
Found dead |
Found dead |
||||||||
Male 3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0* |
0** |
0* |
Female 1 |
Found dead |
Found dead |
||||||||
Female 2 |
0 |
Found dead |
0 |
Found dead |
||||||
Female 3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0** |
0* |
2500 mg/kg bw |
|
|
||||||||
Male 1 |
Found dead |
Found dead |
||||||||
Male 2 |
Found dead |
Found dead |
||||||||
Male 3 |
2 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Female 1 |
2 |
0 |
0 |
0 |
|
0 |
0 |
0 |
0 |
0 |
Female 2 |
Found dead |
Found dead |
||||||||
Female 3 |
Found dead |
Found dead |
Where
* = epidermal scaling
** = necrosis
Additional calculated LD values and 95% confidence limits:
The LD16 for males was 1095.3 mg/kg with a 95% confidence limit of 507.6 to 2363.5 mg/kg. The LD16 for females was 1298.4 mg/kg with a 95% confidence limit of 806.9 to 2089.1 mg/kg. The LD16 combined was 1201.9 mg/kg with a 95% confidence limit of 792.4 to 1822.8 mg/kg.
The LD 84 for males was 3402.3 mg/kg with a 95% confidence limit of 1231.7 to 9398.3 mg/kg. The LD84 for females was 2753.5 mg/kg with a 95% confidence limit of 1588.3 to 4773.4 mg/kg. The LD84 combined was 3015.4 mg/kg with a 95% confidence limit of 1796.1 to 5062.5 mg/kg.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- This study evaluated the dermal toxicity of the test substance following a single dermal application to rabbits. The acute dermal LD50 was calculated to be 1903.7 with a 95% confidence limit of 1462.1 to 2478.7 mg/kg in male and female rabbits.
- Executive summary:
N/A
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
Tato webová stránka používá cookies, aby se vám naše stránky používaly co nejlépe.